News
May 14, 2025 Alnylam drops Covid vaccine patent case against Pfizer ... immunization campaign. Moderna says FDA has been constructive, but delays flu/COVID shot Moderna on Thursday pushed back ...
Moderna researchers reported that the combo shot produced a stronger immune response against COVID-19 and most flu ... “I agree in this case with FDA that efficacy data are important to see ...
Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 ... agree in this case with FDA that ...
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people from getting ...
Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 ... agree in this case with the FDA ...
The mRNA technology is used in approved COVID-19 and RSV shots, but has not yet been approved for a flu shot. Moderna believes ... “I agree in this case with FDA that efficacy data are important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results